从一种骨形成剂过渡到另一种骨形成剂的治疗:对特里巴和罗莫苏祖马布的回顾性队列研究
Tomonori Kobayakawa1, Yasuhide Kanayama2, Yuji Hirano3
1Kobayakawa Orthopedic and Rheumatologic Clinic, Fukuroi 437-0061, Shizuoka, Japan.
JBMR plus
|November 28, 2024
概括
连续治疗骨质疏松症的teriparatide随后的romosozumab显著改善了骨矿物质密度比反向序列. 这一发现为优化骨质疏松症管理策略提供了见解.
科学领域:
- 内分泌学 在内分泌学.
- 整形外科 整形外科 整形外科
- 药理学 药理学是指药理学的学科.
背景情况:
- 骨质疏松症的治疗往往涉及连续使用骨形成剂.
- 特里巴拉提德和罗莫苏祖马布是用于骨质疏松症管理的合成代谢药物.
- 了解这些药物的最佳测序对于最大限度地提高治疗疗效至关重要.
研究的目的:
- 在骨质疏松症中评估使用 teriparatide 和 romosozumab 的顺序治疗的有效性.
- 为了比较两个顺序治疗组之间的骨矿物质密度 (BMD) 变化和治疗目标的实现.
主要方法:
- 多中心回顾性队列研究.
- 有两个组:特里巴拉提德转化为罗莫苏祖马布 (T2R,n=69) 和罗莫苏祖马布转化为特里巴拉提德 (R2T,n=25).
- 12个月的随访评估骨质量,骨循环标志物和不良事件.
主要成果:
- 与R2T (-0.0%) 相比,T2R组显示腰椎骨质量显著增加 (+10.8%).
- T2R组也在整个部和大腿部表现出更大的BMD增长.
- 在T2R组中,更多的患者实现了腰椎T-score> -2.5.5.
结论:
- 从teriparatide到romosozumab的顺序治疗在增加BMD方面比反向顺序更有效.
- 这一序列可能会改善骨质疏松症治疗结果.
- 进一步的研究可能会探索长期影响和患者特异性考虑.
更多相关视频
07:20Author Spotlight: Integrating Traditional Chinese Medicine with Modern Pharmacology and Genomics for Assessing Postmenopausal Osteoporosis in Mice
Published on: August 23, 2024
444
04:19Minimally Invasive Treatment for Thoracolumbar Burst Fracture Using Sagittal Alignment Screws and A Trauma Reduction Device
Published on: November 8, 2024
358
相关概念视频
Bone Remodeling
38.1K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.1K
Osteoclasts in Bone Remodeling
2.8K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
2.8K
Bone Disorders
3.4K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.4K
Hormones and Bone Tissue
2.6K
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
2.6K
Role of Vitamins in Maintaining Bone Health
3.2K
The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
3.2K
